X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with Cadila Healthcare - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs CADILA HEALTHCARE - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD CADILA HEALTHCARE ALEMBIC LTD/
CADILA HEALTHCARE
 
P/E (TTM) x 139.0 32.5 427.3% View Chart
P/BV x 5.2 6.4 80.1% View Chart
Dividend Yield % 0.2 0.7 29.8%  

Financials

 ALEMBIC LTD   CADILA HEALTHCARE
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
CADILA HEALTHCARE
Mar-17
ALEMBIC LTD/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs53460 11.5%   
Low Rs29305 9.6%   
Sales per share (Unadj.) Rs4.792.1 5.1%  
Earnings per share (Unadj.) Rs8.814.8 59.2%  
Cash flow per share (Unadj.) Rs9.018.5 48.7%  
Dividends per share (Unadj.) Rs0.153.20 4.7%  
Dividend yield (eoy) %0.40.8 43.7%  
Book value per share (Unadj.) Rs27.768.0 40.8%  
Shares outstanding (eoy) m267.031,023.74 26.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x8.74.2 209.4%   
Avg P/E ratio x4.725.8 18.1%  
P/CF ratio (eoy) x4.620.7 22.0%  
Price / Book Value ratio x1.55.6 26.3%  
Dividend payout %1.721.6 7.9%   
Avg Mkt Cap Rs m10,962391,581 2.8%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m23815,002 1.6%   
Avg. sales/employee Rs ThNM5,594.5-  
Avg. wages/employee Rs ThNM890.1-  
Avg. net profit/employee Rs ThNM899.9-  
INCOME DATA
Net Sales Rs m1,26094,295 1.3%  
Other income Rs m2641,286 20.5%   
Total revenues Rs m1,52495,581 1.6%   
Gross profit Rs m8319,036 0.4%  
Depreciation Rs m613,750 1.6%   
Interest Rs m0450 0.1%   
Profit before tax Rs m28516,122 1.8%   
Minority Interest Rs m0338 0.0%   
Prior Period Items Rs m2,0960-   
Extraordinary Inc (Exp) Rs m-32-3 1,073.3%   
Tax Rs m61,289 0.5%   
Profit after tax Rs m2,34315,168 15.4%  
Gross profit margin %6.620.2 32.5%  
Effective tax rate %2.18.0 26.8%   
Net profit margin %185.916.1 1,155.6%  
BALANCE SHEET DATA
Current assets Rs m1,68960,223 2.8%   
Current liabilities Rs m48653,058 0.9%   
Net working cap to sales %95.47.6 1,255.8%  
Current ratio x3.51.1 306.0%  
Inventory Days Days21770 310.7%  
Debtors Days Days8188 91.9%  
Net fixed assets Rs m1,62472,984 2.2%   
Share capital Rs m5341,024 52.2%   
"Free" reserves Rs m5,96068,576 8.7%   
Net worth Rs m7,40469,600 10.6%   
Long term debt Rs m10424,684 0.4%   
Total assets Rs m8,010152,207 5.3%  
Interest coverage x950.736.8 2,581.5%   
Debt to equity ratio x00.4 4.0%  
Sales to assets ratio x0.20.6 25.4%   
Return on assets %29.310.3 285.1%  
Return on equity %31.621.8 145.2%  
Return on capital %31.317.9 174.5%  
Exports to sales %2.90-   
Imports to sales %28.90-   
Exports (fob) Rs m37NA-   
Imports (cif) Rs m364NA-   
Fx inflow Rs m3721,280 0.2%   
Fx outflow Rs m36510,874 3.4%   
Net fx Rs m-32810,406 -3.2%   
CASH FLOW
From Operations Rs m34613,495 2.6%  
From Investments Rs m-48-29,103 0.2%  
From Financial Activity Rs m-30123,158 -1.3%  
Net Cashflow Rs m-37,556 -0.0%  

Share Holding

Indian Promoters % 64.0 74.8 85.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 8.3 2.4%  
FIIs % 9.7 5.9 164.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 11.0 237.3%  
Shareholders   54,701 44,069 124.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   NATCO PHARMA  PANACEA BIOTECH  WOCKHARDT LTD.  ABBOTT INDIA  AJANTA PHARMA  

Compare ALEMBIC LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; IT Stocks Top Gainers(01:30 pm)

After opening the day marginally higher, share markets in India continued the momentum and are presently trading in green. Sectoral indices are trading on a mixed note, with stocks in the IT sector.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Jan 22, 2018 03:33 PM

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 5-YR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS